MNKD · Mannkind Corp · Executive Compensation

$3.54 +0.11 (+3.09%) Q2 2026 earnings call transcript

Russell 2000 member Rebalance outlook locked

Market Cap

$1.10B

321.54M

Volume · Oct 29 689.01K Avg daily vol (3M) 4.26M

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2021

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Michael Castagna	CEO	$598,462	—	$2,911,592	—	$481,762	$39,017	$4,030,833
Michael E. Castagna	Chief Executive Officer	$598,462	—	$2,911,592	—	$481,762	$39,017	$4,030,833
David B. Thomson	General Counsel and Secretary	$454,835	—	$1,030,395	—	$296,098	$21,967	$1,803,295
Steven Binder	CFO	$447,385	—	$1,028,955	—	$291,814	$32,851	$1,801,005
Steven B. Binder	Chief Financial Officer	$447,385	—	$1,028,955	—	$291,814	$32,851	$1,801,005
Stuart A. Tross	Chief People and Workplace Officer	$383,180	—	$1,027,434	—	$254,896	$14,777	$1,680,287
Joseph Kocinsky	Chief Technology Officer	$401,551	—	$1,028,193	—	$180,698	$26,506	$1,636,948

Fiscal 2020

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Michael E. Castagna	Chief Executive Officer	$495,192	—	$2,580,300	—	$450,625	$37,178	$3,563,295
Michael Castagna	CEO	$495,192	—	$2,580,300	—	$450,625	$37,178	$3,563,295
David B. Thomson	General Counsel and Secretary	$429,089	—	$1,032,800	—	$278,908	$20,744	$1,761,541
Steven B. Binder	Chief Financial Officer	$396,154	—	$1,032,800	—	$257,500	$21,057	$1,707,511
Steven Binder	CFO	$396,154	—	$1,032,800	—	$257,500	$21,057	$1,707,511
Joseph Kocinsky	Chief Technology Officer	$378,822	—	$1,032,800	—	$246,234	$17,869	$1,675,725
Stuart A. Tross	Chief People and Workplace Officer	$361,490	—	$1,032,800	—	$234,969	$41,916	$1,309,684

Fiscal 2019

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Michael E. Castagna	Chief Executive Officer	$510,962	—	$90,000	$617,568	$285,117	$48,118	$1,551,765
Michael Castagna	CEO	$510,962	—	$90,000	$617,568	$285,117	$48,118	$1,551,765
David M. Kendall	Chief Medical Officer	$434,317	$50,000	$55,168	$247,450	$201,958	$25,968	$1,014,862
David B. Thomson	General Counsel and Secretary	$442,754	—	$64,988	$247,450	$205,880	$27,338	$988,410
Steven Binder	CFO	$408,769	—	$59,999	$247,450	$190,078	$31,555	$937,851
Steven B. Binder	Chief Financial Officer	$408,769	—	$59,999	$247,450	$190,078	$31,555	$937,851
James P. McCauley	Chief Commercial Officer	$408,769	—	$59,999	$247,450	$190,078	$15,212	$921,509

Fiscal 2018

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Michael E. Castagna	Chief Executive Officer	$500,000	$20,000	—	$833,040	$150,000	$5,701	$1,508,741
Michael Castagna	CEO	$500,000	$20,000	—	$833,040	$150,000	$5,701	$1,508,741
David M. Kendall	Chief Medical Officer	$367,789	$50,000	—	$461,670	$91,947	$175,495	$1,146,901
James P. McCauley	Chief Commercial Officer	$400,000	—	—	$333,840	$100,000	$231,642	$1,065,482
David B. Thomson	General Counsel and Secretary	$433,255	$20,000	—	$333,840	$108,314	$19,716	$915,125
Steven Binder	CFO	$400,000	—	—	$333,840	$100,000	$20,452	$854,292
Steven B. Binder	Chief Financial Officer	$400,000	—	—	$333,840	$100,000	$20,452	$854,292

Fiscal 2017

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Michael E. Castagna	PharmD Chief Executive Officer	$458,718	—	—	$606,160	$247,708	$20,648	$1,333,234
Michael Castagna	CEO	$458,718	—	—	$606,160	$247,708	$20,648	$1,333,234
David B. Thomson	Ph.D., J.D. General Counsel and Secretary	$435,839	—	—	$151,076	$193,936	$36,234	$817,085
Steven B. Binder	Chief Financial Officer	$176,923	$50,000	—	$190,204	$79,615	$18,581	$515,323
Steven Binder	CFO	$176,923	$50,000	—	$190,204	$79,615	$18,581	$515,323

Executive changes

Person	Role	Change	Effective	Filed
Lauren Sabella	Executive Vice President, Operations	Retired	2025-07-18	2025-01-06
Lauren Sabella	Executive Vice President, Operations	Appointed	2025-01-06	2025-01-06
Steven B. Binder	Board	Appointed	2024-09-30	2024-08-14
Kent Kresa	Board of Directors	Retired	2024-09-30	2024-08-14
Christopher Prentiss	principal accounting officer	Appointed	2024-04-22	2024-03-26
Christopher Prentiss	Chief Financial Officer and principal accounting officer	Appointed	2024-04-22	2024-03-26
Steven B. Binder	principal accounting officer	Retired	2024-04-22	2024-03-26
Steven B. Binder	Chief Financial Officer and principal accounting officer	Retired	2024-04-22	2024-03-26
Christine Mundkur	director	Appointed	2023-05-25	2023-05-30
Kent Kresa	director	Appointed	2023-05-25	2023-05-30
Sabrina Kay	director	Appointed	2023-05-25	2023-05-30
Anthony Hooper	director	Appointed	2023-05-25	2023-05-30
Michael A. Friedman	director	Appointed	2023-05-25	2023-05-30
Jennifer Grancio	director	Appointed	2023-05-25	2023-05-30
Ronald J. Consiglio	director	Appointed	2023-05-25	2023-05-30
Michael E. Castagna	director	Appointed	2023-05-25	2023-05-30
James S. Shannon	director	Appointed	2023-05-25	2023-05-30
Lauren M. Sabella	Executive Vice President, Chief Operating Officer	Appointed	2023-03-27	2023-03-27

Leadership

Michael Castagna CEO, Board Member
Michael E. Castagna CEO, Board Member
James S. Shannon Chairman
Christopher Prentiss CFO, Chief Accounting Officer
Steven Binder CFO
Lauren M. Sabella COO
Joseph Kocinsky CTO
David B. Thomson General Counsel
Rosabel R. Alinaya Head of Investor Relations
James S. Shannon, M.D., MRCP (UK) Board Member
Kent Kresa Board Member
Michael A. Friedman, M.D. Board Member
Michael E. Castagna, Pharm.D. Board Member
Sabrina Kay, Ed.D. Board Member
Steven B. Binder Board Member

Key facts CIK 899460 CUSIP 56400P706 13F (30d) 56 filings 54 filers Visit website Investor relations